Music |
Video |
Movies |
Chart |
Show |
Atossa Therapeutics calls for at-risk women to begin breast cancer screening at 35 (Proactive Investors) View | |
Atossa Therapeutics backing Endoxifen in the fight against breast cancer (Proactive Investors) View | |
Atossa Therapeutics announces 30% enrollment for Phase 2 I-Spy breast cancer clinical trial (Proactive Investors) View | |
() View | |
() View | |
() View | |
() View | |
() View | |
() View | |
() View |